<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">global-journal-of-medical-research-b-pharma-drug-discovery-toxicology-medicine</journal-id>
<journal-title-group>
<journal-title>Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology &amp; Medicine</journal-title>
</journal-title-group>
<issn publication-format="print">0975-5888</issn>
<issn publication-format="electronic">2249-4618</issn>
<publisher><publisher-name>Global Journals Publishing Group Incorporated</publisher-name></publisher>
<self-uri xlink:href="https://globaljournals.org/journal-seo-export/jats/59643.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">59643</article-id>
<title-group>
<article-title>Development Of Formulation and Technology of Combined Generic Powder for Oral Solution in Sachets Based on the Quality by Design Approach</article-title>
<subtitle>Optimization of Effervescent Powder Formulation</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Panysheva</surname><given-names>Dr.</given-names></name><xref ref-type="aff" rid="aff1" />
</contrib>
<contrib contrib-type="author"><name><surname>Panysheva</surname><given-names>Oksana</given-names></name></contrib>
</contrib-group>
<aff id="aff1">UKRAINE</aff>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-07-09">
<day>09</day>
<month>07</month>
<year>2022</year>
</pub-date>
<volume>22</volume>
<issue>B2</issue>
<fpage>77</fpage>
<lpage>98</lpage>
<abstract><p>Using quality by design approaches (dispersion analysis and random balance method), the formulation and technology of powder for oral solution in sachetswere developed. It includes paracetamol, ascorbic acid, phenylephrine hydrochloride, and pheniramine maleate. The influence of 27 excipients from 5 functional groups on 11 quality attributes was established by the dispersion analysis. The preferred excipients were selected using the utility function. The quantities of preferable excipients (7 quantitative factors at three levels) were researched by the random balance method. Their influence on 11 pharmaco-technological parameters of the powder and the physical properties of the solution studied. The optimal composition of the powder for the oral solution established.9 sequences of introducing components were analyzed by dispersion analysis. The optimal technology of the powderfor oral solution in sachets byroll compaction is established.</p></abstract>
<kwd-group kwd-group-type="author-generated">
<kwd>chemistry</kwd>
<kwd>pharmaceutical; drug development; powders; drugs</kwd>
<kwd>generic; risk assessment; quality indicators.</kwd>
</kwd-group>
<self-uri content-type="pdf" xlink:href="https://globaljournals.org/GJMR_Volume22/11-Development-of-Formulation-and-Technology.pdf" />
<self-uri content-type="html" xlink:href="https://globaljournals.org/scholarly-articles/development-of-formulation-and-technology-of-combined-generic-powder-for-oral-solution-in-sachets-based-on-the-quality-by-design-approach/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>Using Quality by design approaches (dispersion analysis and random balance method), the formulation and technology of powder for oral solution in sachets, which includes paracetamol, ascorbic acid, phenylephrine hydrochloride and pheniramine maleate, have been developed. The influence of 27 excipients from 5 functional groups on 11 quality attributes was studied by the dispersion analysis. The preferred excipients were selected using the utility function.</p>
</sec>
</body>
</article>